Vena caval filters for the prevention of pulmonary embolism

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 10, 2020, Pages

  Young, Tim ^a   Sriram, Krishna Bajee ^a  

^a GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL EFFECTIVENESS; DEEP VEIN THROMBOSIS; DEVICE REMOVAL; EVIDENCE BASED PRACTICE; HUMAN; INCIDENCE; LEG THROMBOSIS; LUNG EMBOLISM; MORTALITY RATE; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADVERSE DEVICE EFFECT; COMPLICATION; INFERIOR CAVA VEIN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIPLE TRAUMA; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; VEIN THROMBOSIS; VENA CAVA FILTER;

ANTICOAGULANT AGENT;

ANTICOAGULANTS; COMBINED MODALITY THERAPY; HUMANS; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; MULTIPLE TRAUMA; PULMONARY EMBOLISM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; VENA CAVA FILTERS; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 85092094018     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006212.pub5     Document Type: Review

References (77)

1. Barginear MF, Gralla RJ, Akerman M, Lesser M, Bradley TP, Shapira I, et al. Is there an advantage to adding inferior vena cava filter (IVCF) placement to anticoagulation with fondaparinux in patients with cancer and venous thromboemboli (VTE): results of the Cancer and Thrombosis (CAT) prospective randomised clinical trial (RCT). Journal of Clinical Oncology 2011;29 (Suppl):abstr 9063. x-wiley/crsRef/14692392
2. Barginear MF, Gralla RJ, Bradley TP, Ali SS, Shapira I, Greben C, et al. Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux in patients with cancer and venous thromboembolism in a prospective randomised clinical trial. Supportive Care Cancer 2012;20(11):2865-72. x-wiley/crsRef/14692393
3. Gralla RJ, Barginear MF, Ackerman M, Lesser M, Bradley T, Shapira I, et al. Results of the CAT (Cancer And Thrombosis) prospective randomised clinical trial testing the addition of an IVC filter to fondaparinux. Supportive Care in Cancer 2011;19(2 Suppl):S192-3. x-wiley/crsRef/14692394
4. Fullen WD, Miller EH, Steele WF, McDonough JJ. Prophylactic vena caval interruption in hip fractures. Journal of Trauma 1973;13(5):403-10. x-wiley/crsRef/2720506
5. Ho KM, Rao S, Honeybul S, Zellweger R, Wibrow B, Lipman J, et al. A multicenter trial of vena cava filters in severely injured patients. New England Journal of Medicine 2019;381(4):328-37. x-wiley/crsRef/14692396 [DOI: 10.1056/NEJMoa1806515] [PMID: 31259488]
6. Ho KM, Rao S, Honeybul S, Zellweger R, Wibrow B, Lipman J, et al. Detailed assessment of benefits and risks of retrievable inferior vena cava filters on patients with complicated injuries: the da Vinci multicentre randomised controlled trial study protocol. BMJ Open 2017;7(7):e016747. x-wiley/crsRef/14692397 [DOI: 10.1136/bmjopen-2017-016747] [PMID: 28706106]
7. Decousus H, Barral F, Buch-muller A, Charbonnier B, Girard P, Lamer C, et al. Eight-year follow-up of patients with permanent vena cava filter in the prevention of pulmonary embolism. Circulation 2005;112(3):416-22. x-wiley/crsRef/2720508
8. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. New England Journal of Medicine 1998;338(7):409-15. x-wiley/crsRef/2720509
9. Decousus H. Eight-year follow-up of a randomized trial investigating vena cava filters in the prevention of PE in patients presenting a proximal DVT: the PREPIC trial. Journal of Thrombosis and Haemostasis 2003;1(Suppl 1):Abstract OC440. x-wiley/crsRef/2720510 [MEDLINE: 6457]
10. Mismetti P, Ennezat PV, Quéré I, Jeannot S, Barral FG, Couturaud F, et al. Prevention of pulmonary embolism recurrences by retrievable vena cava filter: results of the randomized multicenter trial PREPIC 2. Journal of Thrombosis and Haemostasis 2013;11 (Suppl 2):28. x-wiley/crsRef/14692398
11. Mismetti P, Laporte S, Pellerin O, Ennezat P, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. Journal of the American Medical Association 2015;313(16):1627-35. x-wiley/crsRef/2720512
12. Mismetti P, Mottier D, Decousus H, Ennezat PV, Quere I, Schmidt J, et al. A randomized multicenter trial to assess the efficacy and safety of retrievable vena cava filter for the prevention of pulmonary embolism recurrences. Fundamental and Clinical Pharmacology 2014;28 (Suppl 1):25. x-wiley/crsRef/14692399
13. Mismetti P. Randomized trial assessing the efficacy of the partial interruption of the inferior vena cava by an optional vena caval filter in the prevention of the recurrence of pulmonary embolism. PREPIC 2 trial: prevention of embolic recurrences by caval interruption (prospective, multicentric, randomised, open trial). Revue de Pneumologie Clinique 2008;64(6):328-31. x-wiley/crsRef/14692400
14. NCT00457158. PREPIC 2: Prevention of recurrent pulmonary embolism by vena cava interruption (PREPIC2). clinicaltrials.gov/ct2/show/NCT00457158 (first posted 4 April 2007). x-wiley/crsRef/14692401
15. Pellerin O, Barral F, Sanchez O, Midulla M, Mismetti P, Sapoval M, et al. Optional vena cava filter placement and 3 months retrievability: results of the PREPIC 2 randomised multicenter trial. Journal of Vascular and Interventional Radiology 2014;25(3 (Suppl)):S84. x-wiley/crsRef/2720514
16. Usoh F, Hingorani A, Ascher E, Shiferson A, Patel N, Gopal K, et al. Prospective randomised study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters. Journal of Vascular Surgery 2010;52(2):394-9. x-wiley/crsRef/2720516
17. Bocharov AV, Cherenkov VG, Ukhanov AP, Chentsov VI. Potential endovascular prophylaxis for pulmonary thromboembolism in the combined treatment of cancer patients. Voprosy Onkologii 2011;57:513-6. x-wiley/crsRef/2720518
18. Brasel K, Borgstrom DC, Weigelt JA. Cost-effective prevention of pulmonary embolus in high-risk patients. Journal of Trauma, Injury, Infection and Critical Care 1997;42(3):456-62. x-wiley/crsRef/2720520
19. Gosin JS, Graham AM, Ciocca RG, Hammond JS. Efficacy of prophylactic vena caval filters in high-risk trauma patients. Annals of Vascular Surgery 1997;11:100-5. x-wiley/crsRef/2720522
20. Khansarinia S, Dennis JW, Veldenz HC, Butcher LC, Hartland L. Prophylactic Greenfield filter placement in selected high-risk trauma patients. Journal of Vascular Surgery 1995;22:231-6. x-wiley/crsRef/2720524
21. Midy D, Pheline P, Baste JC. Antheor percutaneous filter endocaval filter. Multicentre evaluation based on 300 cases [Filtre endocave percutane antheor. Evaluation multicentrique a propos de 300 cas]. Journal de Maladies Vasculaires 1994;19(4):308-13. x-wiley/crsRef/2720526
22. NCT00423683. Anticoagulation and inferior vena cava filters in cancer patients with a venous thromboembolism. clinicaltrials.gov/ct2/show/NCT00423683 (first posted 18 January 2007). x-wiley/crsRef/14692403
23. NCT02201277. ODEN Trial: Option vs. Denali IVC filters (ODEN). clinicaltrials.gov/ct2/show/NCT02201277 (first posted 23 July 2014). x-wiley/crsRef/14692405
24. Pan Y, Mei J, Wang L, Shao M, Zhang J, Wu H, et al. Investigation of the incidence of periopeperative pulmonary embolism in patients with below-knee deep vein thrombosis after lower extremity fracture and evaluation of retrievable inferior vena cava filter deployment in these patients. Annals of Vascular Surgery 2019;60:45-51. x-wiley/crsRef/14692407
25. Rajasekhar A, Lottenberg L, Lottenberg R. A pilot study on the randomisation of inferior vena cava filter placement for venous thromboembolism prophylaxis in high-risk trauma patients. Journal of Trauma, Injury, Infection and Critical Care 2011;71:323-8. x-wiley/crsRef/14692409
26. Rodriguez JL, Lopez JM, Proctor MC, Conley JL, Gerndt SJ, Marx VM, et al. Early placement of prophylactic vena caval filters in injured patients at high risk for pulmonary embolism. Journal of Trauma, Injury, Infection and Critical Care 1996;40(5):797-804. x-wiley/crsRef/2720530
27. Rogers FB, Shackford SR, Ricci MA, Huber BM, Atkins T. Prophylactic vena caval filter insertion in selected high-risk orthopaedic trauma patients. Journal of Orthopaedic Trauma 1997;11(4):267-72. x-wiley/crsRef/2720532
28. Rosenthal D, McKinsey JF, Levy AM, Lamis PA, Clark MD. Use of the Greenfield filter in patients with major trauma. Cardiovascular Surgery 1994;2(1):52-5. x-wiley/crsRef/2720534
29. Rosner MK, Kuklo TR, Tawk R, Moquin R, Ondra SL. Prophylactic placement of an inferior vena cava filter in high-risk patients undergoing spinal reconstruction. Neurosurgical Focus 2004;17(4):1-6. x-wiley/crsRef/2720536
30. Sharifi M, Bay C, Skrocki L, Lawson D, Mazdeh S. Role of IVC filters in endovenous therapy for deep venous thrombosis: the FILTER-PEVI (filter implantation to lower thromboembolic risk in percutaneous endovenous intervention) trial. Cardiovascular and Interventional Radiology 2012;35(6):1408-13. x-wiley/crsRef/2720538
31. Stavropoulos SW, Chen JX, Sing RF, Elmasri F, Silver MJ, Powell A, et al. Analysis of the final DENALI trial data: a prospective, multicentre study of the Denali inferior vena cava filter. Journal of Vascular and Interventional Radiology 2016;27:1531-8. x-wiley/crsRef/14692411
32. Webb LX, Rush PT, Fuller SB, Meredith WJ. Greenfield filter prophylaxis of pulmonary embolism in patients undergoing surgery for acetabular fracture. Journal of Orthopaedic Trauma 1992;6(2):139-45. x-wiley/crsRef/2720540
33. ACTRN12612001071819. A randomised study to compare the technical difficulty of retrieval between the Bard G2X and the Cook Celect Vena Cava Filter systems in patients at high risk for pulmonary embolism. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=336779 (first posted 8 October 2012). x-wiley/crsRef/14692413
34. ChiCTR1900023485. Prospective multi-center, randomized, controlled trial to assess the safety and performance of the ballet vena cava filter system for the precaution of pulmonary embolism. chictr.org.cn/showprojen.aspx?proj=38298 (first posted 31 May 2019). x-wiley/crsRef/14692415
35. NCT00588757. Comparison between two optional IVC filters regarding ease of use, complications and outcome. clinicaltrials.gov/ct2/show/NCT00588757 (first posted 9 January 2008). x-wiley/crsRef/14692417
36. NCT03070834. RIPT Feasibility Trial (RIPT). clinicaltrials.gov/ct2/show/NCT03070834 (first posted 6 March 2017). x-wiley/crsRef/14692419
37. NCT03691753. Safety and efficacy study of Fitaya vena cava filter. clinicaltrials.gov/ct2/show/NCT03691753 (first posted 2 October 2018). x-wiley/crsRef/14692421
38. NCT03987321. Retrievability and incidence of complex retrieval in Celect versus Denali filter. clinicaltrials.gov/ct2/show/NCT03987321 (first posted 17 June 2019). x-wiley/crsRef/14692423
39. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schunemann HJ, American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive Summary. Antithrombotic Therapy and Prevention of Thrombosis 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2):7S-47S.
40. Kearon C, Akl EA, Ornelas J, Blaivis A, Jimenez D, Bournameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016;149(2):315-52.
41. American College of Radiology (ACR) and the Society of Interventional Radiology (SIR). ACR–SIR Practice parameter for the performance of inferior vena cava (IVC) filter placement for the prevention of pulmonary embolism. acr.org/Quality-Safety/Standards-Guidelines/Practice-Guidelines-by-Modality/Interventional (accessed 26 November 2015).
42. Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011;123:1788-1830.
43. Brown JD, Raissi D, Han Q, Adams VR, Talbert JC. Vena cava filter retrieval rates and factors associated with retrieval in a large US cohort. Journal of American Heart Association 2017;6(9):e006708.
44. Baglin TP, Brush J, Streiff M. Guidelines on use of vena cava filters: British Committee for Standards in Haematology. British Journal of Haematology 2006;134:590-5.
45. Carter S, Thurston DE. Immuno-oncology agents for cancer therapy. Pharmaceutical Journal 2020;304(7937):S2-27. [DOI: 10.1211/PJ.2020.20207825]
46. Chiu V, O'Connell C. Management of the incidental pulmonary embolism. American Journal of Roentgenology 2017;208(3):485-8.
47. Deso SE, Ibrahim AI, Kuo WT. Evidence-based evaluation of inferior vena cava filter complications based on filter type. Seminars in Interventional Radiology 2016;33(2):93-100.
48. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. Journal of the American Medical Association 1998;279(6):458-62.
49. Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Eastern Assocation for the Surgery of Trauma Practice Management Guidelines. Journal of Trauma 2002;53(1):142-64.
50. Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, et al, the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. European Heart Journal 2014;35(43):3033–73.
51. Gomes MPV, Kaplan KL, Deitcher SR. Patients with inferior vena cava filters should receive chronic thromboprophylaxis. Medical Clinics of North America 2003;87:1189-203.
52. McMaster University (developed by Evidence Prime, Inc) GRADEpro Guideline Development Tool. Version accessed 23 January 2018. Hamilton (ON): McMaster University (developed by Evidence Prime, Inc), 2015. Available from gradepro.org.
53. Greenfield LJ. Evolution of venous interruption for pulmonary thromboembolism. Archives of Surgery 1992;127(5):622-6. [MEDLINE: 1575633]
54. Greenspan RH, Ravin CE, Polanksy SM, McLoud TC. Accuracy of the chest radiograph in diagnosis of pulmonary embolism. Investigative Radiology 1982;17(6):539-43.
55. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6.
56. Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Reviews 2005;19:179-202.
57. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
58. Imberti D, Ageno W, Carpenedo M. Retrievable vena caval filters: a review. Current Opinion in Haematology 2006;13:351-6.
59. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, McQuay HJ. Clinical trials: is blinding necessary? Controlled Clinical Trials 1996;17:1-12.
60. Kalva SP, Chlapoutaki C, Wicky S, Greenfield AJ, Waltman AC, Athanasoulis A. Suprarenal inferior vena cava filters: a 20-year single-center experience. Journal of Interventional and Vascular Radiology 2008;19:1041-7.
61. Karmy-Jones R, Jurkovich GJ, Velmahos GC, Burdick T, Spaniolas K, Todd SR, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multicenter study. Journal of Trauma Injury, Infection and Critical Care 2007;62:17-25.
62. Kinney TB. Update on inferior vena caval filters. Journal of Vascular and Interventional Radiology 2003;14:425-40.
63. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
64. Leesne ML, Holly B, Bhagat N, Tamrazi A. Percutaneous removal of permanent IVC filters: tips, tricks, and TrapEases. Journal of Vascular and Interventional Radiology 2015;26:S220-1.
65. Norris CS, Greenfield LJ, Hermann JB. Free-floating iliofemoral thrombus: a risk of pulmonary embolism. Archives of Surgery 1985;120:806-8.
66. Owens CA, Bui JT, Knuttinen G, Gaba RC, Carrillo TC. Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. Journal of Vascular and Interventional Radiology 2010;21:779-87.
67. PIOPED investigators. Value of the ventilation/perfusion scan in pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis. Journal of the American Medical Association 1990;263(20):2753-9.
68. Radomski JS, Jarrell BE, Carabasi RA, Yang S-L, Koolpe H. Risk of pulmonary embolus with inferior vena caval thrombosis. American Surgeon 1987;53:97-101.
69. Rajeshekar A, Streiff MB. Vena cava filters for managment of venous thromboembolism: a clinical review. Blood Reviews 2013;27(5):225-41.
70. Rowland SP, Dharmarajah B, Moore HM, Lane TR, Cousins J, Ahmed AR, et al. Inferior vena cava filters for prevention of venous thromboembolism in obese patients undergoing bariatric surgery: a systematic review. Annals of Surgery 2015;261(1):35-45.
71. Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of anti-hemostatic medicinal products in non-surgical patients. Journal of Thrombosis and Haemostasis 2005;3(4):692-4.
72. Sutherland T, O'Donnell C. The artefacts of death: CT post-mortem findings. Journal of Medical Imaging and Radiation Oncology 2017;62(2):203-10.
73. Tapson VF, Hazelton JP, Myers J, Roberson C, Gilani R, Dunn JA, et al. Evaluation of a device combining an inferior vena cava filter and a central venous catheter for preventing pulmonary embolism among critically ill trauma patients. Journal of Vascular and Interventional Radiology 2017;28(9):1248-54.
74. Young T, Aukes J, Hughes R, Tang H. Vena caval filters for prevention of pulmonary embolism. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No: CD006212. [DOI: 10.1002/14651858.CD006212]
75. Young T, Aukes J, Hughes R, Tang H. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No: CD006212. [DOI: 10.1002/14651858.CD006212.pub2]
76. Young T, Tang H, Aukes J, Hughes R. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No: CD006212. [DOI: 10.1002/14651858.CD006212.pub3]
77. Young T, Tang H, Hughes R. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database of Systematic Reviews 2010, Issue 2. Art. No: CD006212. [DOI: 10.1002/14651858.CD006212.pub4]